Table 3.

Highly recommended BCRL outcome domains for time-constrained environments that measure the ICF domain of body structures and functions

Phase outcome	n	% of responses	% of respondents*	Phase outcome	n	% of responses	% of respondentsa
Pre-surgical (n = 76)				Acute (73)
Joint function	43	13.9	56.6	Joint function	21	7.4	28.8
Flexibility	41	13.2	53.9	Flexibility	21	7.4	28.8
Strength	31	10.0	40.8	Strength	8	2.8	11.0
Volume	66	21.3	86.8*	Volume	72	25.5	98.6*
Pain	32	10.3	42.1	Pain	49	17.4	67.1
Sensation	11	3.5	14.5	Sensation	22	7.8	30.1
Tissue consistency	39	12.6	51.3	Tissue consistency	67	23.8	91.8*
Body composition	24	7.7	31.6	Body composition	22	7.8	30.1
Stages of lymphedema	23	7.4	30.3	Chronic (73)
Post-surgical (n = 75)				Joint function	23	7.9	31.5
Joint function	38	10.3	50.7	Flexibility	25	8.6	34.2
Flexibility	45	12.2	60.0	Strength	13	4.5	17.8
Strength	24	6.5	32.0	Volume	69	23.8	94.5*
Volume	72	19.6	96.0*	Pain	39	13.4	53.4
Pain	55	14.9	73.3*	Sensation	18	6.2	24.7
Sensation	25	6.8	33.3	Tissue consistency	68	23.4	93.2*
Tissue consistency	53	14.4	70.7*	Body composition	35	12.1	47.9
Body composition	12	3.3	16.0
Stages of lymphedema	44	12.0	58.7
Subclinical/surveillance (74)
Joint function	23	7.9	31.1
Flexibility	20	6.9	27.0
Strength	13	4.5	17.6
Volume	71	24.5	95.9*
Pain	42	14.5	56.8
Sensation	19	6.6	25.7
Tissue consistency	62	21.4	83.8*
Body composition	40	13.8	54.1

BCRL-Breast cancer-related lymphedema, ICF-International classification of functioning, Disability and Health

^aMultiple responses for “select all”–the percent of respondents that chose each outcome measure as a highly recommended OM for the respective phase

^*Met the minimum consensus threshold of 70%